PONTREMOLI, ROBERTO
 Distribuzione geografica
Continente #
EU - Europa 22.825
Totale 22.825
Nazione #
IT - Italia 22.825
Totale 22.825
Città #
Genova 16.085
Genoa 2.795
Rapallo 2.135
Vado Ligure 1.771
Bordighera 39
Totale 22.825
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 192
Left ventricular dilatation and subclinical renal damage in primary hypertension 184
Early renal abnormalities as an indicator of cardiovascular risk in type 2 diabetes 169
Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: Insights from the Associazione Medici Diabetologi Annals initiative 156
Increased renal resistive index in patients with essential hypertension: a marker of target organ damage. 153
Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 153
Metabolic syndrome is associated with left ventricular dilatation in primary hypertension 153
Chronic kidney disease in hypertension under specialist care: the I-DEMAND study 152
Ambulatory arterial stiffness index and renal abnormalities in primary hypertension 150
ABNORMALITIES IN AMINO ACID METABOLISM IN CHRONIC RENAL FAILURE 145
Characterization of the calpastatin defect in erythrocytes from patients with essential hypertension. 143
Antihypertensive Treatment and Renal Protection: the role of drugs inhibiting the renin-angiotensin-aldosterone system. 142
Cardiovascular and renal effects of hyperuricaemia and gout. 139
Peripheral artery disease and blood pressure profile abnormalities in hemodialysis patients 139
Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes 138
C-reactive protein and target organ damage in untreated patients with primary hypertension. 136
Uric Acid Promotes Apoptosis in Human Proximal Tubule Cells by Oxidative Stress and the Activation of NADPH Oxidase NOX 4 136
Impact of target organ damage assessment in the evaluation of global risk in patients with essential hypertension. 135
Mild hyperuricemia and subclinical renal damage in untreated primary hypertension 135
Natural history and risk factors for diabetic kidney disease in patients with T2D: lessons from the AMD-annals 134
Prevalence of micro- and macroalbuminuria and their relationship with other cardiovascular risk factors in essential hypertension. 133
Subclinical functional and structural renal abnormalities predict new onset type 2 diabetes in patients with primary hypertension 133
The liver and the kidney: two critical organs influencing the atherothrombotic risk in metabolic syndrome. 132
Vitamin D modulates the association of circulating insulin-like growth factor-1 with carotid artery intima-media thickness 132
Independent association of ECG abnormalities with microalbuminuria and renal damage in hypertensive patients without overt cardiovascular disease: data from Italy-Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Disease study. 132
The role of calpain in the selective increased phosphorylation of the anion-transport protein in red cell of hypertensive subjects. 130
5,10-Methylenetetrahydrofolate reductase polymorphism and early organ damage in primary hypertension. 129
Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS 129
Combined effect of albuminuria and estimated glomerular filtration rate on cardiovascular events and all-cause mortality in uncomplicated hypertensive patients 128
Antihypertensive treatment and renal protection: Is there a J-curve relationship? 128
Use of nifedipine in the treatment of hypertension. 127
Antihyperglycemic treatment in patients with type 2 diabetes in Italy: The impact of age and kidney function 127
Creatinine clearance and early signs of target organ damage in primary hypertension 126
Baseline hs-CRP predicts hypertension remission in metabolic syndrome 126
Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure 126
Post-biopsy arteriovenous fistulas of the native kidneys diagnosed by Doppler US 125
Predicting cardiovascular risk using creatinine clearance and an artificial neural network in primary hypertension 125
The calpastatin defect in hypertension is possibly due to a specific degradation by calpain. 124
Apparent Treatment Resistant Hypertension, Blood Pressure Control and the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes 124
Amino acid imbalance in patients with chronic renal failure. 123
Renin–angiotensin–aldosterone system blockade in chronic kidney disease: current strategies and a look ahead 123
Mild renal dysfunction and renal vascular resistance in primary hypertension 123
Combined use of urinary neutrophil gelatinase-associated lipocalin (uNGAL) and albumin as markers of early cardiac damage in primary hypertension. 123
Uric acid and angiotensin II additively promote inflammation and oxidative stress in human proximal tubule cells by activation of toll-like receptor 4. 123
Microalbuminuria identifies overall cardiovascular risk in essential hypertension: an artificial neural network-based approach. 122
Highlights from International Congress 122
METABOLIC SYNDROME AND CARDIOVASCULAR RISK IN PRIMARY HYPERTENSION. 122
Coronary flow reserve is impaired in hypertensive patients with subclinical renal damage 122
Plasma Triglycerides and HDL-C Levels Predict the Development of Diabetic Kidney Disease in Subjects With Type 2 Diabetes: The AMD Annals Initiative 122
Metabolic syndrome and ambulatory arterial stiffness index in non-diabetic patients with primary hypertension. 121
Antihypertensive Treatment in Diabetic Kidney Disease: The Need for a Patient-Centered Approach 121
Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients 121
Midwall fractional shortening identifies extracardiac organ damage in essential hypertension 120
Blood pressure variability and multiple organ damage in primary hypertension 120
Inappropriate left ventricular mass is associated with microalbuminuria independently of left ventricular hypertrophy in primary hypertension 120
Predictors of renal complications in pediatric patients with type 1 diabetes mellitus: A prospective cohort study 120
Blood pressure levels and control in Italy: Comprehensive analysis of clinical data from 2000-2005 and 2005-2011 hypertension surveys 120
Kidney disease measures are associated with the burden of coronary atherosclerosis, independently of diabetes 120
Reliability of retinal microcirculation measurements by scanning laser Doppler flowmetry in humans 119
Renal ammoniagenesis in man with chronic potassium depletion. 118
Role of the fixed-dose combination lercanidipine-enalapril in renal protection. 118
Overall health assessment: a renal perspective. 118
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 118
Hyperuricemia and renal risk 118
Global Cardiovascular Risk Assessment in the Management of Primary Hypertension: The Role of the Kidney 117
Effects of a protein meal on blood amino acid profile in patients with chronic renal failure. 117
Characteristics of current heart failure patients admitted to internal medicine vs. cardiology hospital units: the VASCO study 117
Application of Temporary Filter During Percutaneous Transcatheter Embolization with Macro Coils of High-flow Massive Renal Arteriovenous Fistula 116
Microalbuminuria in primary hypertension: a guide to optimal patient management? 116
Renal and cardiac abnormalities in primary hypertension 116
Exploring New Options for Cardiovascular Disease Prevention May Improve Patients’ Quality of Life and Outcomes 116
Acute renal failure due to acute bilateral renal artery thrombosis: successful surgical revascularization after prolonged anuria. 115
Association of kidney disease measures with risk of renal function worsening in patients with hypertension and type 2 diabetes 115
Insulin activation of red blood cell Na+/H+ exchange decreases the affinity of sodium sites. 114
Multiple venous sampling for catecholamine assay in the diagnosis of malignant pheochromocytoma 112
Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension 112
RAAS Inhibition and Renal Protection 112
Can we predict outcome by noninvasive assessment of renal haemodynamics in hypertension? The role of renal resistive index 112
Five-Year Predictors of Insulin Initiation in People with Type 2 Diabetes under Real-Life Conditions 112
Diffusion-weighted MRI sequences (DW-MRI) of the kidney: normal findings, influence of hydration state and repeatibility of results 111
Hypernatremia associated with severe rhabdomyolysis. 111
Chronic kidney disease and albuminuria in arterial hypertension. 111
Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes 111
Hyperuricemia is associated with increased hospitalization risk and healthcare costs: Evidence from an administrative database in Italy 111
Microalbuminuria and subclinical cerebrovascular damage in essential hypertension 110
Mild renal dysfunction and cardiovascular risk in hypertensive patients. 110
microalbuminuria in essential hypetension: its relation to cardiovascular risk factors 109
Normoalbuminuric kidney impairment in patients with T1DM: Insights from annals initiative 109
Nephrolithiasis by Corynebacterium urealyticum infection: Literature review and case report 109
Vascular permeability, blood pressure, and organ damage in primary hypertension 109
Renal metabolism of amino acids in early insulin-dependent diabetes mellitus 108
SERUM URIC ACID AS A RISK FACTOR FOR CARDIOVASCULAR AND RENAL DISEASE AN OLD CONTROVERSY REVIVED. 108
Epidemiology of diabetic kidney disease in adult patients with type 1 diabetes in Italy: The AMD-Annals initiative 108
Blood pressure status and the incidence of diabetic kidney disease in patients with hypertension and type 2 diabetes 108
Serum uric acid as a marker of target organ damage in primary hypertension 107
Renal ammoniagenesis in humans with chronic potassium depletion 107
Role of microalbuminuria in the assessment of cardiovascular risk in essential hypertension 107
Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study 107
Cardiovascular and renal risk assessment as a guide for treatment in primary hypertension. 106
Trends in Prevalence, Awareness, Treatment, and Control of Blood Pressure Recorded From 2004 to 2014 During World Hypertension Day in Italy 105
Totale 12.438
Categoria #
all - tutte 73.595
article - articoli 73.072
book - libri 0
conference - conferenze 0
curatela - curatele 324
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 199
Totale 147.190


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.931 0 0 0 0 0 0 0 482 646 976 629 198
2020/20212.223 115 219 191 169 109 169 209 226 188 260 157 211
2021/20222.755 91 142 136 289 118 279 175 652 148 286 110 329
2022/20232.616 263 159 24 273 386 471 47 209 449 62 214 59
2023/20241.401 72 198 36 146 133 266 72 83 82 14 93 206
2024/20252.778 104 344 150 298 600 455 428 399 0 0 0 0
Totale 23.353